Comprehensive Classification of Adverse Drug Reactions Affecting the Skin

Diverse Manifestations of Drug-Induced Skin Reactions

Adverse drug reactions can present dermatologically in a wide variety of ways. Below is an exhaustive classification of the most common clinical presentations associated with drug exposure:

• Drug-induced acne: Manifestation ranging from localized pustules to acute and generalized conditions acute y generalized, including exanthematous with the presence of pustular.
• Diffuse induced by medication.
• Anaphylaxis.
• Angioedema.
• Sjögren's Baboon Syndrome.
• Photosensitivity bullous drug-induced.
• Vasculitis cutaneous.
• Adverse reactions cutaneous reactions associated with antibiotic use.
• Generalized drug eruptions (known as widespread or generalized eruptions) widespread o widespread).
• Syndrome of renal to drugs.
• Drug-triggered psoriasis.
• Hives induced by drugs.
• Drugs that induce erythroderma.
• Fixed drug fixed eruption due to drug exposure.
• Flagellate Erythema.
• Hyperhidrosis secondary to pharmacological agents.
• Drug-induced lupus erythematosus.
• Dermatitis Nummular provoked by drugs.
• Drug-induced pemphigus.
• Photosensitivity caused by drugs.
• Pigmentation cutaneous secondary to medication.
• Drug-induced vitiligo.
• Hand-foot syndrome.
• Lichenoid lichenoid related to amalgam fillings.
• Lichenoid eruption secondary to drugs.
• Fixed drug rash (maculopapular presentation maculopapular o An exanthem or toxic erythema generalized).
• Drug-induced oral mucosal lichenoid eruption.
• Pseudoporphyria.
• Serum Sickness.
• Serum sickness-like reactions.
• Severe cutaneous adverse reaction (SCAR).
• Stevens-Johnson Syndrome / Necrolysis toxic Other conditions that cause significant edema in the superficial dermis include mild (SJS/TEN).
• SDRIFE: Symmetric intertriginous and flexural intertriginous and flexion symmetrical associated with drugs.
• Hives.

Identification of Specific Drugs Causing Skin Toxicity

Certain pharmacological groups or individual agents are recognized for their high propensity to trigger adverse cutaneous effects, whether chronic or potentially severe. Identifying these correlations is fundamental for the rigorous practice of pharmacovigilance and patient safety:

• Anticonvulsants and their adverse impact on the skin.
• Cutaneous side effects derived from targeted therapies against melanoma.
• Cutaneous adverse reactions caused by psychotropic drugs..
• Post-vaccination cutaneous adverse reactions.
• Dermatologic toxicity associated with Arsenic use.
• Inhibitors of the epidermal of Calcineurin Inhibitors.
• Chrysiasis, as a sign of potential Oral non-steroidal anti-inflammatory drugs (NSAIDs), such as diclofenac, can relieve discomfort and reduce redness in skin affected by rosacea. Although rare with use, potential serious adverse effects of these medications include peptic from gold administration.

It is essential to maintain continuous surveillance of these clinical manifestations, as the speed and accuracy in identifying drug-induced cutaneous adverse reactions are decisive for their successful management and the prevention of serious sequelae.